Myoglobin Protects Breast Cancer Cells Due to Its ROS and NO Scavenging Properties

被引:15
|
作者
Quinting, Theresa [1 ]
Heymann, Anna Katharina [1 ]
Bicker, Anne [2 ]
Nauth, Theresa [2 ]
Bernardini, Andre [1 ]
Hankeln, Thomas [2 ]
Fandrey, Joachim [1 ]
Schreiber, Timm [1 ,3 ,4 ]
机构
[1] Univ Duisburg Essen, Inst Physiol, Essen, Germany
[2] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut Mol Genet & Genome Ana, Mainz, Germany
[3] Univ Witten Herdecke, Inst Physiol Pathophysiol & Toxicol, Witten, Germany
[4] Univ Witten Herdecke, Ctr Biomed Educ & Res, Witten, Germany
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词
myoglobin; breast cancer; HIF; hypoxia; ROS; NO; tumor; INDUCIBLE FACTOR-I; HYDROGEN-PEROXIDE; NITRIC-OXIDE; ENDOGENOUS MYOGLOBIN; HYPOXIA; EXPRESSION; TUMOR; OXYGEN; HIF-1-ALPHA; NECROSIS;
D O I
10.3389/fendo.2021.732190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myoglobin (MB) is an oxygen-binding protein usually found in cardiac myocytes and skeletal muscle fibers. It may function as a temporary storage and transport protein for O-2 but could also have scavenging capacity for reactive oxygen and nitrogen species. In addition, MB has recently been identified as a hallmark in luminal breast cancer and was shown to be robustly induced under hypoxia. Cellular responses to hypoxia are regulated by the transcription factor hypoxia-inducible factor (HIF). For exploring the function of MB in breast cancer, we employed the human cell line MDA-MB-468. Cells were grown in monolayer or as 3D multicellular spheroids, which mimic the in vivo avascular tumor architecture and physiology with a heterogeneous cell population of proliferating cells in the rim and non-cycling or necrotic cells in the core region. This central necrosis was increased after MB knockdown, indicating a role for MB in hypoxic tumor regions. In addition, MB knockdown caused higher levels of HIF-1 alpha protein after treatment with NO, which also plays an important role in cancer cell survival. MB knockdown also led to higher reactive oxygen species (ROS) levels in the cells after treatment with H2O2. To further explore the role of MB in cell survival, we performed RNA-Seq after MB knockdown and NO treatment. 1029 differentially expressed genes (DEGs), including 45 potential HIF-1 target genes, were annotated in regulatory pathways that modulate cellular function and maintenance, cell death and survival, and carbohydrate metabolism. Of these target genes, TMEFF1, TREX2, GLUT-1, MKNK-1, and RAB8B were significantly altered. Consistently, a decreased expression of GLUT-1, MKNK-1, and RAB8B after MB knockdown was confirmed by qPCR. All three genes of interest are often up regulated in cancer and correlate with a poor clinical outcome. Thus, our data indicate that myoglobin might influence the survival of breast cancer cells, possibly due to its ROS and NO scavenging properties and could be a valuable target for cancer therapy.</p>
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer Cells
    Aboouf, Mostafa A.
    Armbruster, Julia
    Thiersch, Markus
    Guscetti, Franco
    Kristiansen, Glen
    Schraml, Peter
    Bicker, Anne
    Petry, Ruben
    Hankeln, Thomas
    Gassmann, Max
    Gorr, Thomas A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [2] Elemene Nanoemulsion Inhibits Metastasis of Breast Cancer by ROS Scavenging
    Han, Bo
    Wang, Tao
    Xue, Zhigang
    Wen, Tao
    Lu, Ling
    Meng, Jie
    Liu, Jian
    Wu, Sizhu
    Yu, Jianchun
    Xu, Haiyan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 6035 - 6048
  • [3] Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-κB pathway
    Gupta, Subash C.
    Singh, Ramesh
    Pochampally, Radhika
    Watabe, Kounosuke
    Mo, Yin-Yuan
    ONCOTARGET, 2014, 5 (23) : 12070 - 12082
  • [4] Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack
    Scherbakov, Alexander M.
    Stefanova, Lidia B.
    Sorokin, Danila V.
    Semina, Svetlana E.
    Berstein, Lev M.
    Krasil'nikov, Mikhail A.
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (20) : 3150 - 3159
  • [5] Doxorubicin-Induced Autophagolysosome Formation Is Partly Prevented by Mitochondrial ROS Elimination in DOX-Resistant Breast Cancer Cells
    Ahmadpour, Seyedeh Tayebeh
    Desquiret-Dumas, Valerie
    Yikilmaz, Ulku
    Dartier, Julie
    Domingo, Isabelle
    Wetterwald, Celine
    Orre, Charlotte
    Gueguen, Naig
    Brisson, Lucie
    Maheo, Karine
    Dumas, Jean-Francois
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [6] Targeting Mitochondrial ROS Production to Reverse the Epithelial-Mesenchymal Transition in Breast Cancer Cells
    Monti, Elena
    Mancini, Alessandro
    Marras, Emanuela
    Gariboldi, Marzia Bruna
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (11) : 5277 - 5293
  • [7] Transcriptomic Response to Acidosis Reveals Its Contribution to Bone Metastasis in Breast Cancer Cells
    Yamagata, Ana Sayuri
    Freire, Paula Paccielli
    Jones Villarinho, Nicolas
    Teles, Ramon Handerson Gomes
    Francisco, Kelliton Jose Mendonca
    Jaeger, Ruy Gastaldoni
    Freitas, Vanessa Morais
    CELLS, 2022, 11 (03)
  • [8] Myoglobin mutant with enhanced nitrite reductase activity regulates intracellular oxidative stress in human breast cancer cells
    Tong, Xin-Yi
    Yang, Xin-Zhi
    Teng, Xinchen
    Gao, Shu-Qin
    Wen, Ge-Bo
    Lin, Ying-Wu
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2022, 730
  • [9] The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells
    Yang, Chang-En
    Lee, Wen-Ying
    Cheng, Hung-Wei
    Chung, Chu-Hung
    Mi, Fu-Lowng
    Lin, Cheng-Wei
    CHEMICO-BIOLOGICAL INTERACTIONS, 2019, 302 : 28 - 35
  • [10] Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment
    Barreto Pires, Bruno Ricardo
    Soares De Amorim, Isis Salviano
    Duarte E Souza, Layane
    Rodrigues, Juliana Alves
    Mencalha, Andre Luiz
    ANTICANCER RESEARCH, 2016, 36 (11) : 5681 - 5691